BrainStorm Cell Therapeutics’ Adult Stem Cell Approach More Relevant Than Embryonic Stem Cell Therapies
BrainStorm Cell Therapeutics Inc. (OTCBB:BCLI), a leading developer of adult stem cell technologies and therapeutics, is pleased to announce that based on studies conducted to date, the Company’s adult stem cell therapies provide a safer approach at curing and treating neurodegenerative diseases than competitive therapies that rely on embryonic stem cells. [click link for full article]
More: continued here
Filed under: Stem Cell Research on December 2nd, 2007